Abstract:Background: Shaoyao decoction (SYD), a traditional Chinese medicine prescription that originated in the JinYuan Dynasty, has shown effects in treating ulcerative colitis. However, the underlying mechanism is unclear. We combined network pharmacology with molecular biology technology to detect the mechanism underlying the effect of SYD on ulcerative colitis. We combined network pharmacology with molecular biology technology to detected the further mechanism in SYD effect on ulcerative colitis.Purpose: In this study, we investigated the mechanism by which SYD exerts a protective effect against ulcerative colitis in vivo and in vitro.Study design and methods: We focused on two aspects of the mechanism by which SYD relieves ulcerative colitis, regulation of the MAPK cascade and the NF-kappa B signaling pathway, through analysis of the "active ingredienttarget-disease" network followed by GO enrichment and KEGG pathway analysis according to network pharmacology. Mice with ulcerative colitis underwent 5% dextran sulfate sodium (DSS), and the RAW 264.7 cell model was used to identify important targets.Results: We found that after 5% DSS treatment, the inflammation indexes and the expression of NLRP3-related proteins were increased concomitant with the loss of mucins and occludin. Treatment with SYD (2.25 g/kg, BW) significantly improved the expression of mucins and occludin after DSS at the protein and transcriptional levels. Furthermore, SYD treatment significantly reduced NF-kappa B P65 and P38 expression, thus exerting a great antinecrotic effect, as revealed by TUNEL staining and Western blotting. The beneficial effects of SYD were almost canceled by NSC 95397 (an inhibitor of mitogen-activated protein kinase phosphatase-1 (MKP1)) after DSS treatment in vivo or LPS treatment in vitro. In addition, treatment with SYD reduced caspase-1 activity and rescued the release of ASC and GSDMD, thus inhibiting the assembly of NLRP3 and maintaining the integrity of the intestinal barrier. We also conducted in vitro experiments in the LPS-induced RAW 264.7 cell model and found that cells incubated with 1 mg/ml SYD for 24 h possessed the highest cell viability. Next, we incubated 1 mg/ml SYD for 24 h after treatment with 1 mu g/ml LPS for 6 h. We showed that 1 mg/ml SYD displayed antiinflammatory and anti-necrotic effects through the NLRP3, NF-kappa B P65 and P38 pathways, and the effects of SYD were also inhibited by 10 nM NSC 95397.Conclusion: These results demonstrate that SYD has protective effects against ulcerative colitis and alleviates pyroptosis by inhibiting the MKP1/NF-kappa B/NLRP3 pathway.

Nourishing Yin and Moistening Dryness Formula Inhibits Colon Cell Apoptosis Via Activating the PI3K/AKT Signaling Pathway to Ameliorate Yin-deficiency Constipation in Mice

Modulating Effects of a Functional Food Containing Dendrobium Officinale on Immune Response and Gut Microbiota in Mice Treated with Cyclophosphamide

The Methanol Extract of <i>Polygonatum odoratum</i> Ameliorates Colitis by Improving Intestinal Short-Chain Fatty Acids and Gas Production to Regulate Microbiota Dysbiosis in Mice

Xiaoyankangjun Tablet Alleviates Dextran&nbsp;Sulfate&nbsp;Sodium-Induced Colitis by Regulating Nrf2/HO-1 and JAK2/STAT3 Pathway and Gut Microbiota

Laxative Effects of Yangyin Tongmi Capsule on a Model of Diphenoxylate-Induced Constipation in Mice.

Synbiotic yogurt containing konjac mannan oligosaccharides and Bifidobacterium animalis ssp. lactis BB12 alleviates constipation in mice by modulating the stem cell factor (SCF)/c-Kit pathway and gut microbiota

Nobiletin, an active component of Wenyang Yiqi Formula, alleviates constipation associated depression through targeting MAPT to inhibit the MAPK signaling pathway

Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats

Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS

A specially designed yogurt supplemented with a combination of pro- and prebiotics relieve constipation in mice and humans

Novel Applications of Yinhua Miyanling Tablets in Ulcerative Colitis Treatment Based on Metabolomics and Network Pharmacology

Shaoyao Decoction Attenuates Dss-Induced Ulcerative Colitis, Macrophage And Nlrp3 Inflammasome Activation Through The Mkp1/Nf-Kappa B Pathway

[Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome]

Xiaoyankangjun tablet alleviates dextran sulfate sodium-induced colitis in mice by regulating gut microbiota and JAK2/STAT3 pathway

Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF-κB pathway

Effect and Mechanism of Functional Compound Fruit Drink on Gut Microbiota in Constipation Mice.

Specially Designed Yogurt Supplemented with Combination of Pro- and Prebiotics Relieved Constipation in Mice and Humans.

The pharmacological validation of the Xiao-Jian-Zhong formula against ulcerative colitis by network pharmacology integrated with metabolomics

Network pharmacological prediction and molecular docking analysis of the combination of Atractylodes macrocephala Koidz. and Paeonia lactiflora Pall. in the treatment of functional constipation and its verification

Soluble dietary fiber and cellulose from Saccharina japonica by-product ameliorate Loperamide-induced constipation via modulating enteric neurotransmitters, short-chain fatty acids and gut microbiota

Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation